0001127602-24-029602.txt : 20241217 0001127602-24-029602.hdr.sgml : 20241217 20241217162219 ACCESSION NUMBER: 0001127602-24-029602 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241214 FILED AS OF DATE: 20241217 DATE AS OF CHANGE: 20241217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gayer Charles K CENTRAL INDEX KEY: 0001800110 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 241555968 MAIL ADDRESS: STREET 1: 4505 EMPEROR BLVD. STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-12-14 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001800110 Gayer Charles K 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Chief Commercial Officer 0 Common Stock 2024-12-14 4 F 0 8251 7.53 D 300057 D Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person. /s/ Alane P. Barnes, by power of attorney 2024-12-17